MedPath

Histological treatment effect of preoperative thrapy/prognostic prediction scoring system for pancreatic cancer -A retrospective observation study

Not Applicable
Conditions
Pancreatic Cancer
Registration Number
JPRN-UMIN000035672
Lead Sponsor
Wakayama Medical University
Brief Summary

The favorable factors were counted as one point. The integrated point equal to and more than 4 was categorized to high score group. Results: OS and RFS in the patients was greater in patients with high score (n=11) than with low score (n=18; log-rank test P=0.03/0.028). Pathological N0 status (P<0.05) and histological response of more than IIb (P<0.05) were found at a significantly higher incidence in high score group.

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete: follow-up complete
Sex
All
Target Recruitment
28
Inclusion Criteria

Not provided

Exclusion Criteria

Those who do not fall under the above.

Study & Design

Study Type
Observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
To evaluate the prediction ability of treatment effect by scoring system with tumor marker (CA19-9, DUPAN-2), tumor size, whole tumor ADC value on diffusion-weighted MRI, and SUVmax value.
Secondary Outcome Measures
NameTimeMethod
To evaluate the prediction ability of prognosis by scoring system with tumor marker (CA19-9, DUPAN-2), tumor size, whole tumor ADC value on diffusion-weighted MRI, and SUVmax value.
© Copyright 2025. All Rights Reserved by MedPath